metforminPapers
Papers about metformin
- papers
- 3,984
Newest first
3,601 to 3,650 of 3,984Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.
Diabetes care2006PMID 16732009
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome.
Cell metabolism2006PMID 16753576
Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling.
The journal of obstetrics and gynaecology research2006PMID 16764619
Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial.
BMJ (Clinical research ed.)2006PMID 16769748
Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus.
Diabetes, obesity & metabolism2006PMID 16776749
Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Diabetes, obesity & metabolism2006PMID 16776753
Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Gynecological endocrinology2006PMID 16785142
Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
European journal of pharmaceutics and biopharmaceutics2006PMID 16797948
The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
BJOG2006PMID 16827766
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study.
Diabetic medicine2006PMID 16842477
Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.
Diabetic medicine2006PMID 16842480
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.
European journal of pharmacology2006PMID 16843455
Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes.
International journal of clinical practice2006PMID 16846398
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
The Journal of clinical endocrinology and metabolism2006PMID 16868063
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
Diabetes care2006PMID 16873786
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis.
Fertility and sterility2006PMID 16879826
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Journal of clinical pharmacy and therapeutics2006PMID 16882108
Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.
European journal of endocrinology2006PMID 16914604
Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione.
Diabetes, obesity & metabolism2006PMID 16918591
Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.
Diabetes care2006PMID 16936143
Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study.
Journal of the American College of Cardiology2006PMID 16949486
Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.
Current medical research and opinion2006PMID 16968575
Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.
Diabetic medicine2006PMID 16978370
The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes.
Diabetic medicine2006PMID 16978371
Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review.
Fertility and sterility2006PMID 17007847
Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin.
Saudi medical journal2006PMID 17013468Indexed under metformin in PubMed's chemical list
Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Current medical research and opinion2006PMID 17022853
Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Diabetes, obesity & metabolism2006PMID 17026489
Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes.
Experimental and clinical endocrinology & diabetes2006PMID 17039422Indexed under metformin in PubMed's chemical list
Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study.
Journal of drugs in dermatology2006PMID 17039655
Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
Journal of diabetes and its complications2006PMID 17070446
The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.
The journals of gerontology2006PMID 17077202
Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.
Experimental and clinical endocrinology & diabetes2006PMID 17115351
Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Clinical endocrinology2006PMID 17121522
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.
Diabetes care2006PMID 17130197
Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome.
The Journal of international medical research2006PMID 17133785
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
The New England journal of medicine2006PMID 17145742
A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
The American journal of psychiatry2006PMID 17151157
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
Hormone and metabolic research2006PMID 17163361
Tolerability and effectiveness of fluoxetine, metformin and sibutramine in reducing anthropometric and metabolic parameters in obese patients.
Arquivos brasileiros de endocrinologia e metabologia2006PMID 17221107Indexed under metformin in PubMed's chemical list
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
Diabetes/metabolism research and reviews2005PMID 15386821
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
The Journal of clinical endocrinology and metabolism2005PMID 15483105
Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
Human reproduction (Oxford, England)2005PMID 15513975
Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.
The Journal of clinical endocrinology and metabolism2005PMID 15536162
The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
Human reproduction (Oxford, England)2005PMID 15576394
Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism2005PMID 15598674
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
Journal of internal medicine2005PMID 15606381
Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Human reproduction (Oxford, England)2005PMID 15618250
Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies.
Diabetes, obesity & metabolism2005PMID 15642073
Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury.
Annals of surgery2005PMID 15650645